Paroxysmal Nocturnal Hemoglobinuria (PNH), Level of CD59 on Red and White Blood Cells in Bone Marrow Failure Syndromes

N/ACompletedNCT01192425

Alexion Pharmaceuticals, Inc.5,580 enrolled

Overview

Examine red and white blood cells of PNH patients with bone marrow failure syndromes.

Study Type

OBSERVATIONAL

Enrollment

5,580

Conditions

Hemoglobinuria

Eligibility

Sex: ALLMin age: 10 Years

Medical Language ↔ Plain English

Inclusion Criteria: * At least 10 years of age. * Has aplastic anemia, myelodysplastic syndromes or other bone marrow failure syndromes Exclusion Criteria: * Has any condition that might interfere with the patient's participation

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.